Paid Clinical Trials in New Hampshire
New Hampshire has 358 paid clinical trials enrolling now across cities including Lebanon, Manchester and Concord. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in New Hampshire include Dartmouth-Hitchcock Medical Center, National Cancer Institute (NCI) and Trustees of Dartmouth College, running studies across oncology, cardiology, neurology, and more. The most actively recruiting conditions are Breast Cancer, Acute Myeloid Leukemia, Multiple Myeloma, Epilepsy — browse the full list or use the filters to match your diagnosis. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
358 clinical trials
↓ Download CSVIndividual Differences in Placebo Analgesic Effects
The Role of the Opioid System in Placebo Effects on Pain and Social Rejection
The Agenda-Setting for Kidney Disease Trial
Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals
Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds
The Agenda-Setting for Kidney Disease Open Pilot Trial
Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation:
In Vivo Imaging of the Olfactory Epithelium Using Confocal Laser Endomicroscopy
The Healing and Empowerment Actions for Recovery From Trauma (HEART) Trial
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Epileptiform Potential of Fully Immersive Virtual Reality
FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma
Study of LGW16-03 To Identify Nerves
aPBI Re-irradiation
Interactions Between Placebo Effects and Mindful Awareness State
Plan and Protect: Safety Planning for Teens in Rural Emergency Departments
Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?
Digitally Enhanced Peer Doula Model for Perinatal Patients With Substance Use Disorder
Comparing the Impact of Peer Support vs. Staff-Delivered Transportation Interventions for Young Adults With Intellectual and Developmental Disabilities.
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
uSafeUS+ App Pilot Testing
Computer Guided Microwave Liver Ablation
Video Inspired Discussions About Ethical Outcomes in Pediatrics
TF-CBT for Autistic Youth Pilot Implementation - Open Pilot
ASKids! Inpatient Agenda-Setting Study for Hospitalized Children With Medical Complexity
Flush, Lyse, Operate
ALPCO 25(OH) Vitamin D CLIA Kit - Fresh Versus Frozen Serum and Plasma Stability Study
Piloting an Insomnia Treatment in Patients With Ulcerative Colitis
Pilot Trial of the Move Healthier Group
Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Mindfulness in a College Physiology Course
Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
ABY-029 Glioma Trial
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
About research studies in New Hampshire
New Hampshire has approximately 358 recruiting research studies across a wide range of therapeutic areas. New Hampshire hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Common conditions studied in New Hampshire
- Breast Cancer (10 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Acute Myeloid Leukemia (6 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Multiple Myeloma (6 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Epilepsy (5 active studies). Epilepsy research focuses on new anti-seizure medications, neuromodulation devices, and precision therapies for genetic epilepsies.
- Pain (5 active studies). Recruiting Pain studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Ulcerative Colitis (5 active studies). Ulcerative colitis trials examine biologic therapies, S1P receptor modulators, and oral small molecules for steroid-sparing remission.
Leading research sponsors in New Hampshire
- Dartmouth-Hitchcock Medical Center
- National Cancer Institute (NCI)
- Trustees of Dartmouth College
- SWOG Cancer Research Network
- Children's Oncology Group
Local regulations and guidelines
Clinical trials in New Hampshire are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Hampshire research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in New Hampshire. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in New Hampshire
Hipa.ai aggregates every recruiting study in New Hampshire from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in New Hampshire?
There are approximately 358 recruiting clinical trials in New Hampshire listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New Hampshire pay participants?
Most recruiting trials in New Hampshire compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New Hampshire?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New Hampshire?
The most common conditions under active study in New Hampshire include Breast Cancer (10), Acute Myeloid Leukemia (6), Multiple Myeloma (6), Epilepsy (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New Hampshire?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Hampshire on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New Hampshire?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.